<abstract xmlns="http://www.w3.org/1999/xhtml"><bold>Purpose</bold>: We aimed to find critical biomakers associated with BRCA1-mutation positive breast cancer.<bold>Methods:</bold> The data set E-MTAB-982 was downloaded from ArrayExpress database and the data were preprocessed using R package Oligo. Differential expression analysis between BRCA1-mutation positive breast cancer patients and BRCA1-mutation positive healthy subjects were performed using limma package. Then, gene set enrichment analysis was conducted. We constructed the network for BRCA1, its related differentially expressed genes (DEGs), and the enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. After that, survival analysis was performed based on the clinical data of breast cancer in TCGA database. Finally, box diagram for key genes was drawn.<bold>Results</bold>: The network showed that LSM3, NDUFB3, GNPDA2, and PTGS2 were BRCA1 related DEGs. Furthermore, LSM3 was mainly enriched in RNA degradation pathway and spliceosome pathway. PTGS2 was enriched in arachidonic acid metabolism and VEGF signaling pathway. Survival analysis indicated that high expression of LSM3 indicated a poor prognosis of BRCA1-mutant breast cancer. Besides, box diagram showed that LSM3 was down-regulated in BRCA1-mutation positive breast cancer patients compared with that in BRCA1-mutation positive healthy subjects.<bold>Conclusions</bold>: LSM3, NDUFB3, and PTGS2 may be biomarkers in BRCA1-mutant breast cancer, and high expression of LSM3 may indicate a poor prognosis of BRCA1-mutant breast cancer.</abstract>

Purpose: We aimed to find critical biomakers associated with BRCA1-mutation positive breast cancer.Methods: The data set E-MTAB-982 was downloaded from ArrayExpress database and the data were preprocessed using R package Oligo. Differential expression analysis between BRCA1-mutation positive breast cancer patients and BRCA1-mutation positive healthy subjects were performed using limma package. Then, gene set enrichment analysis was conducted. We constructed the network for BRCA1, its related differentially expressed genes (DEGs), and the enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. After that, survival analysis was performed based on the clinical data of breast cancer in TCGA database. Finally, box diagram for key genes was drawn.Results: The network showed that LSM3, NDUFB3, GNPDA2, and PTGS2 were BRCA1 related DEGs. Furthermore, LSM3 was mainly enriched in RNA degradation pathway and spliceosome pathway. PTGS2 was enriched in arachidonic acid metabolism and VEGF signaling pathway. Survival analysis indicated that high expression of LSM3 indicated a poor prognosis of BRCA1-mutant breast cancer. Besides, box diagram showed that LSM3 was down-regulated in BRCA1-mutation positive breast cancer patients compared with that in BRCA1-mutation positive healthy subjects.Conclusions: LSM3, NDUFB3, and PTGS2 may be biomarkers in BRCA1-mutant breast cancer, and high expression of LSM3 may indicate a poor prognosis of BRCA1-mutant breast cancer.

<italic>LSM3</italic>, <italic>NDUFB3</italic>, and <italic>PTGS2</italic> may be potential biomarkers for <italic>BRCA1</italic>-mutation positive breast cancer

Affiliated Hospital of Zunyi Medical University

Revista Romana de Medicina de Laborator

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

, , and  may be potential biomarkers for -mutation positive breast cancer

Purpose: We aimed to find critical biomakers associated with BRCA1-mutation positive breast cancer.Methods: The data set E-MTAB-982 was downloaded from...

LSM3, NDUFB3, and PTGS2 may be potential biomarkers for BRCA1-mutation positive breast cancer

Pubblicato online: 18 nov 2020

Pagine: 381 - 391

Ricevuto: 23 lug 2020

Accettato: 28 ott 2020

DOI: https://doi.org/10.2478/rrlm-2020-0037

Parole chiave
BRCA1-mutation, breast cancer, differentially expressed genes, pathways

© 2020 Kang Hu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

LSM3, NDUFB3, and PTGS2 may be potential biomarkers for BRCA1-mutation positive breast cancer

Pubblicato online: 18 nov 2020

Pagine: 381 - 391

Ricevuto: 23 lug 2020

Accettato: 28 ott 2020

DOI: https://doi.org/10.2478/rrlm-2020-0037

Parole chiaveBRCA1-mutation, breast cancer, differentially expressed genes, pathways

© 2020 Kang Hu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Parole chiave
BRCA1-mutation, breast cancer, differentially expressed genes, pathways